EMINENCE ENT completes major acquisition and adjustment of convertible bonds
EMINENCE ENT (00616.HK) announced that a significant acquisition and related transactions were completed on Thursday (15th). The transaction involves the incorporation of ZhuoYi as a wholly-owned subsidiary and its consolidation into the group's financial statements, with a total purchase price of approximately HKD 286 million, to be paid through convertible bonds due in 2025, and involves the issuance of approximately 1.697 billion shares.
In addition, the conversion price of the 2023 convertible bonds has been adjusted from HKD 0.07 per share to HKD 0.05, resulting in an increase in the number of shares to be converted to 490 million shares
Source: AASTOCKS The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments